These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21786611)

  • 1. [Experimental quality assessment of APTT-control reagent kits in the study of plasma with varying Factor VIII activity].
    Staritsyna NN; Shanskaia AI; Papaian LP; Ivanova RP
    Klin Lab Diagn; 2011 May; (5):31-3. PubMed ID: 21786611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental quality assessment of APTT-control reagent kits in the study of heparin-containing plasma in therapeutic ranges].
    Staritsyna NN; Shanskaia AI; Papaian LP; Ivanova RP
    Klin Lab Diagn; 2011 Apr; (4):39-41. PubMed ID: 21735680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of factor VIII:C and factor IX activity in plasmas of haemophilic dogs on the activated partial thromboplastin time measured with two commercial reagents.
    Mischke R
    Haemophilia; 2000 May; 6(3):135-9. PubMed ID: 10792470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand disease masquerading as haemophilia A.
    Mazurier C
    Thromb Haemost; 1992 Apr; 67(4):391-6. PubMed ID: 1631785
    [No Abstract]   [Full Text] [Related]  

  • 5. Activated partial thromboplastin time. A multicenter evaluation of 11 reagents in the screening of mild haemophilia A.
    Scand J Haematol; 1980 Oct; 25(4):308-17. PubMed ID: 6782653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophilia A or von Willebrand disease?
    Batlle J; Blanco-Lopez MJ; Domenech M; Baiget M; Rocha R; Lopez-Fernandez MF
    Ann Hematol; 1994 Dec; 69(6):317-9. PubMed ID: 7993941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of factor VIII:C with a chromogenic substrate.
    Rosén S
    Scand J Haematol Suppl; 1984; 40():139-45. PubMed ID: 6433444
    [No Abstract]   [Full Text] [Related]  

  • 8. Performance characteristics of a commercial kit for assay of factor viii-related antigen.
    Cejka J
    Clin Chem; 1984 May; 30(5):814-5. PubMed ID: 6424967
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of factor VIII:C activity on the activated partial thromboplastin time (aPTT) in the dog. Adaptation of the aPTT as a screening test for canine hemophilia A?].
    Mischke R
    Dtsch Tierarztl Wochenschr; 1993 Jun; 100(6):219-22. PubMed ID: 8339706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific and global coagulation tests in patients with mild haemophilia A with a double mutation (Glu113Asp, Arg593Cys).
    Trampuš Bakija A; Debeljak M; Preložnik Zupan I; Benedik Dolničar M; Kovač J; Jazbec J
    Blood Transfus; 2015 Oct; 13(4):622-30. PubMed ID: 26057490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor, factor VIII and the factor VIII/von Willebrand factor complex.
    Ingerslev J
    Dan Med Bull; 1990 Oct; 37(5):385-406. PubMed ID: 2125548
    [No Abstract]   [Full Text] [Related]  

  • 13. One-Stage Factor VIII Assays.
    Duncan E; Rodgers S
    Methods Mol Biol; 2017; 1646():247-263. PubMed ID: 28804834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies.
    Tokunaga N; Inoue C; Sakata T; Kagawa K; Abe M; Takamatsu N; Nakao T; Doi T
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):474-6. PubMed ID: 26523912
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic diagnosis in hemophilia and von Willebrand disease.
    Swystun LL; James PD
    Blood Rev; 2017 Jan; 31(1):47-56. PubMed ID: 27596108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand's disease, hemophilia A, and factor VIII.
    Snyder DS
    Hum Pathol; 1974 May; 5(3):277-89. PubMed ID: 4545385
    [No Abstract]   [Full Text] [Related]  

  • 17. [The factor VIII complex: hemophilia A and von Willebrand disease].
    Tobelem G; Rothschild C
    Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factor VIII and factor VIII inhibitor].
    Takamatsu J
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():640-2. PubMed ID: 15658411
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
    Veyradier A; Caron C; Ternisien C; Wolf M; Trossaert M; Fressinaud E; Goudemand J
    Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.